Crescent Park Management’s Thermo Fisher Scientific TMO Stock Holding History

Crescent Park Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$503K	Buy	+1,009	New	+$484K	1.24%	11

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Crescent Park Management's TMO Position: Q2 2026 in Review

Crescent Park Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 1,009 shares worth $503K. The stake represents 1.24% of the portfolio and ranks #11 among its holdings.

2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Crescent Park Management held 1,009 shares of Thermo Fisher Scientific worth $503K as of Q2 2026.
Thermo Fisher Scientific was a new Crescent Park Management position in Q2 2026.
Thermo Fisher Scientific made up 1.24% of Crescent Park Management's portfolio in Q2 2026, its #11 holding.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Crescent Park Management's 13F filing for Q2 2026, filed 14 Aug 2026.